Vera Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vera Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Vera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.59M, a 91.2% increase year-over-year.
  • Vera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $17.8M, a 61.6% increase year-over-year.
  • Vera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11.5M, a 29.3% increase from 2022.
  • Vera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.89M, a 195% increase from 2021.
  • Vera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.01M, a 810% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $17.8M $5.59M +$2.67M +91.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $15.1M $4.87M +$2.19M +81.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $13M $4.12M +$1.46M +54.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $11.5M $3.22M +$473K +17.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $11M $2.92M +$471K +19.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $10.5M $2.68M +$657K +32.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $9.89M $2.67M +$1.01M +60.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $8.89M $2.75M +$1.79M +186% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $7.1M $2.45M +$1.52M +163% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.58M $2.03M +$1.31M +184% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.27M $1.66M +$1.26M +311% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.01M $962K +$819K +573% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $2.19M $933K +$878K +1596% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.32M $713K +$641K +890% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $674K $404K +$343K +562% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $331K $143K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $55K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $72K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $61K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.